ELECTION OF LANGUAGE AND MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS

MICROPORT CARDIOFLOW MEDTECH CORPORATION

微创心通医疗科技有限公司

(A company incorporated in the Cayman Islands with limited liability)

(Stock Code: 02160)

29 April 2021

Dear Shareholder(s),

Election of Language and Means of Receipt of Corporate Communications

Pursuant to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and/or the Articles of Association of MicroPort CardioFlow Medtech Corporation (the "Company"), the Company will make available the following options for you to elect for receipt of future corporate communications of the Company ("Corporate Communications"), which means any document(s) issued or to be issued by the Company for the information or action of any holders of its securities, including but not limited to: (a) the annual reports and its summary financial reports (where applicable) (and all reports and accounts contained therein); (b) the interim reports and its summary interim reports (where applicable) (and all reports and accounts contained therein); (c) notices of meetings; (d) listing documents; (e) circulars; and (f) proxy forms, in the following manners:

  1. to read all future Corporate Communications in electronic form published on the Company's website athttps://www.cardioflowmedtech.com("Website Version") instead of receiving printed copies, and to receive a printed notification letter of the publication of the Corporate Communications on the Company's website by post; or
  2. to receive the printed English version of all future Corporate Communications by post only; or
  3. to receive the printed Chinese version of all future Corporate Communications by post only; or
  4. to receive both the printed English and Chinese versions of all future Corporate Communications by post.

In support of environmental protection and for the purpose of saving printing and mailing costs, the Company recommends you to select the Website Version. To make your election, please mark (X) in the appropriate box on the enclosed reply form ("Reply Form") and sign and return it by post or hand delivery to the Company c/o its share registrar (the "Share Registrar"), Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong, on or before 27 May 2021. If you post the Reply Form in Hong Kong, you may use the freepost mailing label in Reply Form and need not to affix a stamp when returning your Reply Form. Otherwise, please affix an appropriate stamp.

If the Company does not receive a duly completed and signed Reply Form from you or a response from you indicating that you object to receive the Website Version of Corporate Communications by 27 May 2021, you will be deemed, until you inform the Company otherwise by reasonable notice in writing at the office of the Share Registrar at the above address or by email to Microportcardioflowmedtech@computershare.com.hk , to have elected to receive all future Corporate Communications by Website Version instead of receiving them in printed form according to the relevant laws and regulations. In that event, when the Company makes Corporate Communications, it will only send you a notification letter that the Corporate Communications have been made available on the Company's website. The notification letter will be sent to you by post at your address as it appears in the Company's register of members maintained by the Share Registrar.

You are entitled have the right to change the choice of language and or means of receipt of the Corporate Communications at any time by reasonable notice in writing or using email at Microportcardioflowmedtech@computershare.com.hkto the Company c/o the Share Registrar. Even if you have chosen (or are deemed to have consented) to receive all future Corporate Communications by Website Version and for any reason have difficulty in obtaining access to the Corporate Communications on the Company's website, the Company will promptly upon your request send the relevant Corporate Communications to you in printed form free of charge.

Please note that: (a) printed copies of the English and Chinese versions of all future Corporate Communications will be available from the Company or the Share Registrar on request; and (b) the same in website version will also be available on the Company's website at https://ir.cardioflowmedtech.com/hk/investor-relations/corporate-governance/and on the news's of Hong King Exchange and Clearing Limited website at www.hkexnews.hk.

Should you have any queries in relation to this letter, please call the Share Registrar's telephone hotline at (852) 2862 8688 during business hours from 9:00 a.m. to 6:00 p.m. from Monday to Friday, excluding Hong Kong public holidays.

By order of the Board

MicroPort CardioFlow Medtech Corporation

Luo Qiyi

Chairman

Attachments

  • Original document
  • Permalink

Disclaimer

Microport Cardioflow Medtech Corporation published this content on 28 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2021 14:33:02 UTC.